ReviewExperimental dermatology2018

Inhibition of interleukin-12 and/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?

Elizabeth N Ergen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.